We are exploring a new treatment combination for patients with ER+, HER2-, and GRPR+ advanced breast cancer who have not responded to earlier therapies. The study aims to assess the safety and effectiveness of this approach.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hormone receptor positive HER2 negative breast cancer is a type of breast cancer that grows in response to hormones like estrogen and progesterone, but does not have excess HER2 protein. This type of cancer often requires specific hormonal therapies for treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
